STRUCTURE AND LUMINESCENCE OF THIETANE-CONTAINING
1209
sidue was treated with 20 ml of distilled water
(2×10 ml), and the solvent was distilled off under
reduced pressure to remove excess hydrazine hydrate.
The precipitate was washed with water and dried.
Yield 0.75 g (75%), mp 175–176°C (from water). IR
spectrum, ν, cm–1: 1654 (C=N); 3028, 3142, 3208 (N–H).
1H NMR spectrum, δ, ppm (J, Hz): 3.24 d.d (2H, cis-
CH2S, J = 8.7, 9.0), 4.07 d.d (2H, trans-CH2S, J = 9.0,
9.2), 5.34–5.70 m (6-H), 7.6 br.s (NH, NH2). 13C NMR
spectrum, δC, ppm: 34.60 t (C7, C8), 55.65 d (C6),
131.69 s (C5), 139.41 s (C3).
1-[3-Bromo-1-(1,1-dioxo-λ6-thietan-3-yl)-1H-
1,2,4-triazol-5-yl]-2-[1-(4-nitrophenyl)ethylidene]hyd-
razine (III). Hydrochloric acid, 0.6 ml, and p-nitro-
acetophenone, 0.73 g (4.4 mmol), were added to a
solution of 1.13 g of 3-bromo-1-(1,1-dioxo-λ6-thietan-
3-yl)-1H-1,2,4-triazol-5-ylhydrazine in a mixture of
50 ml of ethanol and 10 ml of water. The mixture was
heated for 1 h under reflux and cooled, and the
precipitate was filtered off, washed with water, and
dried. Yield 1.27 g (75%), mp 263–265°C (from 1,4-
dioxane). IR spectrum, ν, cm–1: 1138, 1318 (SO2);
1142, 1588 (NO2); 1612 (C=N); 3280, 3304 (N–H). 1H
NMR spectrum, δ, ppm (J, Hz): 2.25 s (CH3, cis), 2.50
s (CH3, trans), 3.38 d.d (2H, cis-CH2SO2, J = 4.4, 4.8),
4.70 d.d (2H, trans-CH2SO2, J = 4.0, 4.4), 5.71–5.82 m
1-[3-Bromo-1-(thietan-3-yl)-1H-1,2,4-triazol-5-
yl]-2-[1-(4-nitrophenyl)ethylidene]hydrazine (I).
p-Nitro-acetophenone, 0.73 g, was added to a solution
of 1.00 g of 3-bromo-1-(thietan-3-yl)-1H-1,2,4-triazol-
5-ylhydrazine in 25 ml of ethanol. The mixture was
heated for 2 h under reflux and cooled, and the
precipitate was filtered off, washed with water, and
dried. Yield 1.42 g (89%), mp 182–184°C (from butan-
1-ol). IR spectrum, ν, cm–1: 1378, 1504 (NO2); 1612
(6-H), 8.25 d (2H, Harom, J = 7.8), 8.33 d (2H, Harom
,
J = 7.8), 8.30 d (2H, Harom, J = 7.9), 7.41 d (2H, Harom
,
J = 7.9). 13C NMR spectrum, δC, ppm: 13.70 q and
18.43 q (CH3), 39.54 d (C6), 70.71 t (C7, C8), 123.40 d
(Carom), 123.41 d (Carom), 126.86 d (Carom), 127.69 d
(Carom), 136.84 (C5), 140.18 (Carom), 143.93 (Carom),
147.30 (Carom), 148.05 (C3), 154.18 and 155.92 (C12).
Mass spectrum, m/z (Irel, %): 428 (60.6) [M]+, 105
(13.1), 324 (15.1), 163 (33.7), 117 (100), 76 (57.7),
382 (3.1).
1
(C=N); 3350 (N–H). H NMR spectrum, δ, ppm (J,
Hz): 2.55 s (3H, CH3), 3.89 d.d (2H, cis-CH2S, J = 8.8,
8.9), 4.03 d.d (2H, trans-CH2S, J = 8.9, 9.1), 6.11–6.32
m (6-H), 8.05 d and 8.31 d (2H each, Harom, J = 8.2),
13
9.62 br.s (NH). C NMR spectrum, δC, ppm: 13.66 q
(C13), 33.59 t (C7, C8), 54.50 d (C6), 124.53 d (Carom),
127.81 d (Carom), 137.83 (C5), 145.18 (Carom), 148.15
(Carom), 148.61 (C3), 153.32 (C12). Mass spectrum, m/z
(Irel, %): 396 (29) [M]+, 73 (100), 324 (93.8), 163 (12),
117 (39.3), 76 (21.2), 350 (10).
REFERENCES
1. Polya, Y.B., Comprehensive Heterocyclic Chemistry,
Katritzky, A.R. and Rees, C.W., Eds., Oxford:
Pergamon, 1984, vol. 5, p. 733.
1-[3-Bromo-1-(1-oxo-λ4-thietan-3-yl)-1H-1,2,4-tri-
azol-5-yl]-2-[1-(4-nitrophenyl)ethylidene]hydrazine
(II). p-Nitroacetophenone, 0.73 g, was added to a
solution of 1.06 g of 3-bromo-1-(1-oxo-λ4-thietan-3-
yl)-1H-1,2,4-triazol-5-ylhydrazine in 50 ml of ethanol.
The mixture was heated for 1.5 h under reflux and
cooled, and the precipitate was filtered off, washed
with water, and dried. Yield 1.50 g (91%), mp 246–
248°C (from 1,4-dioxane). IR spectrum, ν, cm–1: 1340,
1504 (NO2); 1598 (C=N); 3280–3600 (N–H). 1H NMR
spectrum, δ, ppm (J, Hz): 2.52 s (3H, CH3), 3.77 d.d
(2H, cis-CH2SO, J = 8.3, 8.7), 3.97 d.d (2H, trans-
CH2SO, J = 5.6, 8.7), 6.19–6.23 m (1H, 6-H), 8.10 d
and 8.32 d (2H each, Harom, J = 7.9), 9.34 br.s (NH).
13C NMR spectrum, δC, ppm: 13.69 q (C13), 56.73 t
(C7, C8), 56.80 d (C6), 123.60 d (Carom), 126.88 d
(Carom), 136.78 (C5), 143.94 (Carom), 146.88 (C3),
147.07 (Carom), 153.31 (C12). Mass spectrum, m/z (Irel,
%): 412 (68.2) [M]+, 89 (4.2), 324 (8.2), 163 (42.5),
117 (100), 76 (47.2), 366 (8.1), 349 (6.8).
2. Mashkovskii, M.D., Lekarstvennye sredstva (Drugs),
Moscow: Novaya Volna, 2005, vol. 1, p. 1200.
3. Burbello, A.T., Shabrov, A.V., and Denisenko, P.P.,
Sovremennye lekarstvennye sredstva (Modern Drugs),
St. Petersburg: Neva, 2006.
4. Kaplunov, M.G., Krasnikova, S.S., Yakushchenko, J.K.,
Shamaev, S.N., Pivovarov, A.P., Efimov, O.N., Er-
makov, E.N., and Stakharny, S.A., Mol. Cryst. Liq.
Cryst., 2005, vol. 426, p. 287.
5. Tsai, L-R. and Chen, Y., Macromolecules, 2007, vol. 40,
no. 9, p. 2984.
6. Yasuda, T., Imase, T., Nakamura, Y., and Yamamota, T.,
Macromolecules, 2005, vol. 38, no. 11, p. 4687.
7. Wang, Y., Yi, L., Yang, X., Ding, B., Cheng, P., Liao, D-Z.,
and Yan, S.-P., Inorg. Chem., 2006, vol. 45, no. 15,
p. 5822.
8. Zhou, X.-Y., Huang, Y.-Q., and Sun, W.-Y., Inorg. Chim.
Acta, 2009, vol. 362, no. 5, p. 1399.
9. Li, Y., Wang, N., Gan, H., Liu, H., Li, H., He, X.,
Huang, C., Cui, S., Wang, S., and Zhu, D., J. Org.
Chem., 2005, vol. 70, no. 24, p. 9686.
RUSSIAN JOURNAL OF GENERAL CHEMISTRY Vol. 81 No. 6 2011